Lv1
74 积分 2024-10-23 加入
First-Line HER2 ADC and Anti-PD-1 Plus Chemo Shows Efficacy in Gastric Cancer
10小时前
求助中
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
11小时前
已完结
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer
1个月前
已完结
Dual Inhibitors of KRASG12D and HSP90 Are Effective against KRASG12D Inhibitor Resistance
1个月前
已完结
Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T cells in KRAS-Mutant Cholangiocarcinoma
2个月前
已完结
A systems mechanism for KRAS mutant allele-specific responses to targeted therapy
3个月前
已完结
Gasdermin D–mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma
5个月前
已完结
Drug-Tolerant Persister Cells in Cancer Therapy Resistance
5个月前
已完结
The KRASG12C Inhibitor MRTX849 Reconditions the Tumor Immune Microenvironment and Sensitizes Tumors to Checkpoint Inhibitor Therapy
7个月前
已完结
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung Cancer
7个月前
已完结
皖公网安备34019202002308
